PH13959A - Method of treating benign prostatic hypertrophy - Google Patents

Method of treating benign prostatic hypertrophy

Info

Publication number
PH13959A
PH13959A PH19678A PH19678A PH13959A PH 13959 A PH13959 A PH 13959A PH 19678 A PH19678 A PH 19678A PH 19678 A PH19678 A PH 19678A PH 13959 A PH13959 A PH 13959A
Authority
PH
Philippines
Prior art keywords
benign prostatic
prostatic hypertrophy
treating benign
treating
hypertrophy
Prior art date
Application number
PH19678A
Other languages
English (en)
Inventor
J Johnston
H Benson
V Petrow
J Grunwell
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of PH13959A publication Critical patent/PH13959A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
PH19678A 1976-05-10 1977-04-15 Method of treating benign prostatic hypertrophy PH13959A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/684,945 US4055641A (en) 1976-05-10 1976-05-10 Method of treating benign prostatic hypertrophy

Publications (1)

Publication Number Publication Date
PH13959A true PH13959A (en) 1980-11-12

Family

ID=24750167

Family Applications (1)

Application Number Title Priority Date Filing Date
PH19678A PH13959A (en) 1976-05-10 1977-04-15 Method of treating benign prostatic hypertrophy

Country Status (4)

Country Link
US (1) US4055641A (fr)
BE (1) BE854414A (fr)
PH (1) PH13959A (fr)
ZA (1) ZA772087B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2817157A1 (de) * 1978-04-17 1979-10-25 Schering Ag Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie
DE3121152A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie"
DE3121153A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung von aromatase-hemmern zur prophylaxe und therapie der prostatahyperplasie"
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
EP0155934B1 (fr) * 1983-07-29 1989-12-06 Duke University Compositions pharmaceutiques pour le traitement de troubles liés aux androgènes chez les humans
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US5595985A (en) * 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
HUT60139A (en) * 1989-07-07 1992-08-28 Endorecherche Inc Process for producing pharmaceutical composition suitable for treating prostate cancer connected with androgen
ATE170753T1 (de) * 1989-07-07 1998-09-15 Endorecherche Inc Androgenderivate zur hemming der aktivität der sexualsteroide
US5162624A (en) * 1991-10-11 1992-11-10 Duksa Thomas R Flow switch
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US20060079492A1 (en) * 1999-10-25 2006-04-13 Ahlem Clarence N Compositions and treatment methods
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US8759284B2 (en) 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449381A (en) * 1962-06-12 1969-06-10 Syntex Corp 19-oxo- and 19-lower alkyl-19-oxoandrostane derivatives
US3235573A (en) * 1962-12-20 1966-02-15 Syntex Corp 19-lower alkylidene and 19-oxo-delta4-androsten-17beta-ol-3-one derivatives

Also Published As

Publication number Publication date
ZA772087B (en) 1978-06-28
BE854414A (fr) 1977-09-01
US4055641A (en) 1977-10-25

Similar Documents

Publication Publication Date Title
ZA772087B (en) Method of treating benign prostatic hypertrophy
GB1549511A (en) Method of treating plants
JPS5493847A (en) Method of treating undertround water
JPS5329077A (en) Method of treating semiconductor
ZA772085B (en) Method of treating acne
JPS5382052A (en) Method of treating drainage
PH16127A (en) Method of treating benign prostatic hypertrophy
JPS5316464A (en) Highly treating method of organic drainage
JPS549453A (en) Method of treating nighttsoil
JPS5310554A (en) Treating method of nitrogen containing waste water
JPS5342408A (en) Method of treating poor subsoil
JPS52121923A (en) Method of treating coupled portion of wallpaper etc*
JPS5322506A (en) Treating method of fats
ZA772090B (en) Method of treating prostatic carcinoma
JPS5349005A (en) Method of treating slags
JPS5364957A (en) Method of treating drainage
JPS5350305A (en) Method of treating woods
JPS5312401A (en) Method of treating woods
JPS5428453A (en) Method of treating sewage
JPS5464856A (en) Method of treating sewage
JPS52115561A (en) Method of treating water containing metal
JPS52156798A (en) Method of treating boujacite clay
JPS52101856A (en) Method of treating mercuryycontained organic solution
JPS5370552A (en) Method of treating drainage
JPS5382050A (en) Method of treating drainage